IRIS
MORABITO, Nunziata
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.119
EU - Europa 3.644
AS - Asia 1.519
SA - Sud America 13
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 9.307
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.096
IE - Irlanda 1.179
SE - Svezia 1.097
CN - Cina 854
SG - Singapore 507
IT - Italia 429
DE - Germania 289
FI - Finlandia 156
UA - Ucraina 143
PL - Polonia 88
FR - Francia 82
GB - Regno Unito 79
IN - India 60
HK - Hong Kong 43
BE - Belgio 39
CA - Canada 21
CZ - Repubblica Ceca 10
NL - Olanda 10
TR - Turchia 10
KR - Corea 9
VN - Vietnam 9
JP - Giappone 8
RU - Federazione Russa 8
NO - Norvegia 7
CL - Cile 6
ID - Indonesia 6
BR - Brasile 5
CH - Svizzera 5
LT - Lituania 5
AT - Austria 4
BG - Bulgaria 4
EG - Egitto 4
IQ - Iraq 3
RO - Romania 3
SN - Senegal 3
CM - Camerun 2
DK - Danimarca 2
ES - Italia 2
IR - Iran 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
BT - Bhutan 1
CO - Colombia 1
CR - Costa Rica 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
LV - Lettonia 1
MX - Messico 1
MY - Malesia 1
TW - Taiwan 1
Totale 9.307
Salva come PNG Salva come JPEG
Città #
Dublin 1.179
Chandler 866
Nyköping 584
Singapore 418
Jacksonville 416
Beijing 301
Ashburn 236
Princeton 215
Dearborn 194
Medford 171
Ann Arbor 156
Messina 153
Cambridge 131
Des Moines 127
Boardman 116
Bremen 105
New York 91
Warsaw 83
Munich 78
Wilmington 61
Jinan 60
Shenyang 60
Helsinki 53
Nanjing 52
San Mateo 45
Brussels 39
Tianjin 37
Pune 35
Woodbridge 35
Hebei 33
Haikou 28
Guangzhou 27
Nanchang 25
Ningbo 25
Seattle 25
Strasbourg 25
Zhengzhou 25
Catania 24
Taizhou 24
Hangzhou 23
Houston 23
Los Angeles 21
Fuzhou 19
Lancaster 18
Falls Church 15
Fremont 14
Milan 14
Central 11
Hyderabad 11
Jiaxing 11
Taiyuan 11
Lanzhou 10
Rome 10
Sheung Shui 10
Brno 9
Changsha 9
Toronto 9
Dong Ket 8
Leawood 8
Norwalk 7
Chicago 6
Clearwater 6
Fiumefreddo Di Sicilia 6
Jakarta 6
London 6
Rende 6
Bergen 5
Bydgoszcz 5
Hefei 5
Monmouth Junction 5
Ottawa 5
Amsterdam 4
Auburn Hills 4
Cosenza 4
Frankfurt am Main 4
Istanbul 4
Milazzo 4
Redwood City 4
Riva 4
Santa Clara 4
Turin 4
Washington 4
Augusta 3
Curitiba 3
Fairfield 3
Florence 3
Francofonte 3
Izmir 3
Kunming 3
Pound Ridge 3
Sheffield 3
Tokyo 3
Vienna 3
Xiangfen 3
Antalya 2
Archi 2
Ardabil 2
Caltagirone 2
Cave 2
Centuripe 2
Totale 6.782
Salva come PNG Salva come JPEG
Nome #
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? 110
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 106
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 98
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 93
ASSOCIATION BETWEEN COGNITIVE IMPULSIVITY AND BONE MINERAL DENSITY: A CROSS-SECTIONAL STUDY IN POSTMENOPAUSAL WOMEN EVALUATED FOR OSTEOPOROSIS 93
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 90
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 89
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 89
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 85
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 85
Executive functions and bone health: a focus on cognitive impulsivity and bone mineral density 83
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 82
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 80
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 79
null 78
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 78
Amylasemia in uremics: a complex interpretation 77
Role of genetic pattern on bone mineral density in thalassemic patients 77
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 75
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 75
Recombinant erythropoietin and hypertension 73
Association between anxiety levels and osteoporosis in postmenopausal women. 73
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 73
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 72
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 72
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 71
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 70
Frailty and lipid profile in elderly hospitalized patients 69
AB0820 COGNITIVE IMPULSIVITY CORRELATES WITH BONE MINERAL DENSITY 68
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 67
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 65
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 64
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 64
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate. EUROPEAN UROLOGY, vol. 47; p. 575 - 581 63
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 63
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 63
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 63
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 63
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 63
Flushing due to calcitonin and the opioid system 62
Cardiovascular effects of raloxifene hydrochloride 62
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 62
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 62
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 62
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 62
Quality of life in postmenopausal women: Which role for vitamin D? 62
Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with Type 2 Diabetes Mellitus 62
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 62
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 62
Effect of genetic pattern on BMD in Thalassemic Patients: Preliminary report. 61
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 61
Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation 61
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 61
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 61
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 61
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 61
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 60
THE CIRCADIAN-RHYTHM OF ERYTHROPOIETIN IN SUBJECTS WITH PRE- TERMINAL UREMIA 59
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 59
Is erythropoietin-induced hypertension a phenomenon due to the intracellular Ca++ mobilisation? 59
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 59
Vitamin D status is associated with anxiety levels in postmenopausal women evaluated for osteoporosis 59
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 59
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 58
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 58
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 57
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 57
Anxiety levels as risk factor for osteoporosis in postmenopausal women 57
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 57
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 55
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 55
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 55
Clinical psychological evaluation in elderly men with prostatic hypertrophy in treatment with Dutasteride. 55
Raloxifene and mammographic breast density 54
Somministrazione settimanale e giornaliera di alendronato nel trattamento dell'osteoporosi della thalassemia major. 54
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 54
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 54
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 54
Correction: In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia (Endocrine, (2019), 65, 3, (569-579), 10.1007/s12020-019-01908-x) 54
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 53
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 53
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 53
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 53
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 53
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 53
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 53
HANDGRIP STRENGTH TO DISCRIMINATE HIGH FRACTURE RISK IN TYPE 2 DIABETES MELLITUS PATIENTS 53
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 53
Turnover osseo e sistema osteoprotegerina/RANKL nell'osteodistrofia epatica 52
EFFETTI DELLA SOMMINISTRAZIONEDI RANELATO DI STRONZIO SUILIVELLI SIERICI DI IGF-1 IN DONNECON OSTEOPOROSI POSTMENOPAUSALE 52
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis. 52
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 52
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 51
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 51
Amylasemia in uremics: a complex interpretation 51
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 51
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 51
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 51
INFLUENCE OF THE TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN ON PLASMA-CONCENTRATION OF INTERLEUKIN-1-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA IN HEMODIALYZED SUBJECTS 50
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 50
Totale 6.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.206
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020701 0 0 0 0 0 0 124 104 39 249 147 38
2020/2021987 91 17 286 50 132 93 34 45 17 111 59 52
2021/20221.526 13 194 19 58 39 16 153 45 160 246 133 450
2022/20233.460 256 349 165 241 304 324 33 190 1.428 22 104 44
2023/2024923 67 137 43 99 66 200 36 90 6 20 17 142
2024/2025803 64 74 68 259 216 99 23 0 0 0 0 0
Totale 9.672